Welcome to our dedicated page for Dentsply Sirona news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on Dentsply Sirona stock.
DENTSPLY SIRONA Inc. develops, manufactures and markets professional dental products, dental technologies, oral health products and other consumable medical devices under a broad brand portfolio. News for XRAY commonly covers quarterly results, outlook updates, restructuring actions, capital allocation, debt reduction, share repurchases and changes to distribution relationships for dental equipment and connected technology solutions.
Company updates also focus on digital dentistry and imaging products, including CEREC systems, intraoral scanning, CBCT imaging, DS Core, Smart View - Detect and dental-dedicated MRI work with Siemens Healthineers. Additional product news includes Surity urinary incontinence devices from Wellspect HealthCare, along with regulatory clearances, CE markings, commercial launches, board changes and investor conference participation.
DENTSPLY SIRONA Inc. (Nasdaq: XRAY) has announced a 10% increase in its quarterly dividend, raising it from $0.10 to $0.11 per share. The new dividend will be paid on July 9, 2021 to shareholders on record by June 25, 2021. This decision reflects the company’s ongoing commitment to provide value to its investors while maintaining its standing as a leading manufacturer of dental products.
Dentsply Sirona (Nasdaq: XRAY) will participate in four investor conferences in June 2021. Key events include:
- William Blair 41st Annual Growth Stock Conference on June 2 at 9:40am ET
- Stifel 2021 Virtual Jaws & Paws Conference on June 3 at 10:00am ET
- Goldman Sachs 42nd Annual Global Healthcare Conference on June 9 at 9:40am ET
- Baird 2021 Healthcare ESG Symposium on June 17 at 10:40am ET
Live webcasts can be accessed through the Dentsply Sirona website, with replays available afterward.
Dentsply Sirona (Nasdaq: XRAY) reported strong first quarter 2021 results with revenue of $1,027 million, a 17.5% increase from $874 million in Q1 2020. GAAP EPS rose to $0.53 compared to a loss of ($0.63) last year. Non-GAAP EPS increased 67.4% to $0.72. Operating income also improved, reaching $154 million versus a loss of ($125 million) in 2020. The company raised its FY21 Non-GAAP EPS outlook to $2.75 to $2.90, reflecting optimism about the dental market recovery.
Dentsply Sirona, the world's largest manufacturer of dental products, will host an investor conference call and webcast on May 6, 2021, at 8:30 am ET. An earnings press release will be issued that morning. Investors can access the event via the link on Dentsply Sirona’s website. For participation, domestic callers can dial +1-877-370-7637, while international callers can reach +1-629-228-0723, using Conference ID # 3396419. A replay will be available for one week post-call. Dentsply Sirona focuses on innovative dental solutions, and its shares are listed on Nasdaq under the symbol XRAY.
Dentsply Sirona (Nasdaq: XRAY) will participate in the 2021 Barclays Global Healthcare Conference on March 10, 2021. CEO Don Casey is set to join a fireside chat at 1:15 PM ET, which can be accessed via a live audio webcast on the company’s website. A replay will also be available post-event. As the world’s largest manufacturer of professional dental products, Dentsply Sirona has a rich history of 134 years in the dental industry, providing innovative solutions to enhance patient care.
North American Dental Group (NADG) and Dentsply Sirona have announced an expanded partnership aimed at enhancing patient care through advanced digital solutions. This new agreement gives NADG-supported dentists improved access to scanning and imaging technologies, such as Primescan, to support treatments like SureSmile clear aligners and guided implant surgery. The collaboration includes a robust education and training program to establish evidence-based clinical standards across NADG's 250 dental offices in 15 states, emphasizing the commitment to delivering exceptional oral care.
DENTSPLY SIRONA reported Q4 2020 revenue of $1.08 billion, down 2.6% from $1.1 billion in Q4 2019. GAAP EPS fell by 2.2% to $0.45, while non-GAAP EPS rose 19.2% to $0.87. For FY20, total revenue dropped 17.1% to $3.34 billion. Operating cash flow for FY20 remained strong at $635 million. The company announced a fiscal year 2021 outlook, projecting revenue between $4.0 billion and $4.3 billion, representing a growth of 20% to 30%. Non-GAAP EPS for FY21 is expected to range from $2.60 to $2.80.
Dentsply Sirona (Nasdaq: XRAY) has declared a quarterly cash dividend of $0.10 per share, indicating an annual rate of $0.40. The dividend will be payable on April 9, 2021 to stockholders on record as of March 26, 2021. As the largest manufacturer of professional dental products, Dentsply Sirona provides a comprehensive range of innovative solutions to enhance patient care and improve dental practices. This announcement reflects the company's ongoing commitment to returning value to its shareholders.
Dentsply Sirona (Nasdaq: XRAY) will host an investor conference call and live webcast on March 1, 2021, at 8:30 am ET. An earnings press release will be issued earlier that morning. Investors can access the call via the company’s website and participate by calling +1-877-370-7637 (domestic) or +1-629-228-0723 (international) using Conference ID # 8540717. A replay will be available for a week. Dentsply Sirona, the largest manufacturer of dental products, focuses on advancing patient care through innovative solutions.
Dentsply Sirona (Nasdaq: XRAY) will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 13, 2021, at 7:30 AM ET. CEO Don Casey will represent the company during the event. Interested parties can access a live audio webcast of the presentation on their website. A replay will also be available afterward. Dentsply Sirona is the largest manufacturer of dental products and technologies, known for its innovation and quality in the dental industry, with a 132-year history.